| Product NDC: | 0024-1800 |
| Proprietary Name: | SKELID |
| Non Proprietary Name: | tiludronate disodium |
| Active Ingredient(s): | 200 mg/1 & nbsp; tiludronate disodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0024-1800 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020707 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19970307 |
| Package NDC: | 0024-1800-16 |
| Package Description: | 56 TABLET in 1 CARTON (0024-1800-16) |
| NDC Code | 0024-1800-16 |
| Proprietary Name | SKELID |
| Package Description | 56 TABLET in 1 CARTON (0024-1800-16) |
| Product NDC | 0024-1800 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | tiludronate disodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19970307 |
| Marketing Category Name | NDA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | TILUDRONATE DISODIUM |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |